DUBAI – Roche Diagnostics Middle East FZCO today announced the appointment of Guido Sander as General Manager for the Middle East.
Guido Sander has spent over 20 years with Roche around the world and last served as Head of 11 high-growth markets across Asia Pacific (APAC) where he led a diverse team of more than 950 employees, serving 2.3 billion people and positioned Roche Diagnostics as a market leader in APAC region. Guido Sander will succeed Harald Wolf, who has retired after serving the company for over 30 years, in driving business growth and addressing customer and patient needs in the Middle East. He will work towards supporting the transformation of healthcare in the region through long-term partnerships.
“We are delighted to welcome Guido Sander in his new role as General Manager for the Middle East. Guido has been passionate about helping countries improve access to healthcare and address unmet medical needs through our innovative diagnostics solutions. He is also a genuine people leader and I am very confident that he will further drive better health outcomes across the Middle East.” said Bernard Colombo, Head of Europe, Middle East and Africa, and Latin America (EMEA-LATAM) at Roche Diagnostics.
“It is an honor to take on this role. The healthcare sector in the region has been on a steady upward trajectory, owing to the leadership’s continuous effort in creating superb infrastructure as well as access to the latest in-vitro diagnostics. We will continue to support the region by working with our network of partners towards enhancing the quality of healthcare across the public and private sectors, and a continued patient-centric approach”, said Guido Sander, General Manager, Roche Diagnostics Middle East FZCO.
Guido Sander joined Roche in 2002 as Strategic Project Manager in Mannheim, Germany. He has held various leadership positions at Roche Diagnostics across the EMEA-LATAM and APAC regions, including General Manager of Portugal and India respectively, before assuming his former role in 2016.